TBC Brings Biological Computing to AWS with Neuron-Powered AI Optimization
The Biological Computing Company (TBC), founded by neurosurgeons Alex Ksendzovsky and Jon Pomeraniec, has made a significant leap from stealth mode to partnering with Amazon Web Services. In just six months, TBC emerged from stealth in February 2026, announcing a $25 million seed round led by Primary Ventures and opening its flagship wet lab in San Francisco's Mission Bay neighborhood.
TBC's innovative approach uses living rat neurons and human stem-cell-derived neurons to improve AI model performance. The company cultivates these neurons on multi-electrode arrays, which record biological signals that are then translated into software plugins for existing transformer-based AI models. This allows end users to optimize their AI models without needing to touch any biological hardware.
On July 30, TBC released a proof-of-concept targeting Decart's OASIS 500M model, achieving a striking 2x improvement in video quality, 4.4x lower inference costs, and more than 3x improvement in coherent video output compared to the base model.
The company plans to deploy its technology commercially for computer vision and generative video applications before the end of 2026, with a commercial text-to-video model on the roadmap. TBC's technology addresses one of the persistent weaknesses in AI-generated video: object permanence, or keeping track of where things are across video frames.